T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
AES
AES
$9.11B
| $13M | ﹤0.01% |
1,045,566
+38,174
| +4% | +$474K |
|
|
SKX
1052
DELISTED
Skechers
SKX
| $13M | ﹤0.01% |
228,432
-41,130
| -15% | -$2.34M |
|
1053
Broadstone Net Lease
BNL
$3.51B
| $13M | ﹤0.01% |
760,272
+17,316
| +2% | +$295K |
|
1054
MarketAxess Holdings
MKTX
$6.86B
| $12.9M | ﹤0.01% |
59,404
-3,631
| -6% | -$786K |
|
1055
Petrobras Class A
PBR.A
$76.8B
| $12.8M | ﹤0.01% |
979,753
| – | – |
|
1056
Immunovant
IMVT
$2.65B
| $12.7M | ﹤0.01% |
744,544
-171,706
| -19% | -$2.93M |
|
1057
Aecom
ACM
$16.9B
| $12.7M | ﹤0.01% |
136,959
+16,054
| +13% | +$1.49M |
|
1058
Okta
OKTA
$15.8B
| $12.5M | ﹤0.01% |
119,247
+9,686
| +9% | +$1.02M |
|
1059
HEICO Class A
HEI.A
$36B
| $12.5M | ﹤0.01% |
59,140
+4,009
| +7% | +$846K |
|
1060
BlackLine
BL
$3.37B
| $12.5M | ﹤0.01% |
257,181
+3,438
| +1% | +$166K |
|
1061
Fidelity National Financial
FNF
$15.9B
| $12.4M | ﹤0.01% |
190,021
+9,728
| +5% | +$633K |
|
1062
Red Rock Resorts
RRR
$3.53B
| $12.4M | ﹤0.01% |
284,985
+1,532
| +0.5% | +$66.4K |
|
1063
Enphase Energy
ENPH
$5.1B
| $12.3M | ﹤0.01% |
198,388
+4,686
| +2% | +$291K |
|
1064
IonQ
IONQ
$17.6B
| $12.2M | ﹤0.01% |
551,929
-136,835
| -20% | -$3.02M |
|
1065
Janus Henderson
JHG
$6.86B
| $12.2M | ﹤0.01% |
336,482
-14,891
| -4% | -$538K |
|
|
BBOT
1066
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$796M
| $12.1M | ﹤0.01% |
1,071,550
-16,221
| -1% | -$183K |
|
1067
AppFolio
APPF
$9.83B
| $12M | ﹤0.01% |
54,640
-12,095
| -18% | -$2.66M |
|
1068
Albemarle
ALB
$9.51B
| $11.9M | ﹤0.01% |
165,159
+978
| +0.6% | +$70.4K |
|
1069
Cadre Holdings
CDRE
$1.35B
| $11.9M | ﹤0.01% |
401,727
+4,544
| +1% | +$135K |
|
1070
T. Rowe Price US Equity Research ETF
TSPA
$1.97B
| $11.8M | ﹤0.01% |
+336,418
| New | +$11.8M |
|
1071
Huntington Ingalls Industries
HII
$10.7B
| $11.8M | ﹤0.01% |
57,681
-3,351
| -5% | -$684K |
|
1072
Virtus Investment Partners
VRTS
$1.3B
| $11.7M | ﹤0.01% |
68,071
-2,900
| -4% | -$500K |
|
1073
Hasbro
HAS
$10.4B
| $11.7M | ﹤0.01% |
190,480
+2,609
| +1% | +$160K |
|
1074
OGE Energy
OGE
$8.88B
| $11.7M | ﹤0.01% |
254,739
-54,017
| -17% | -$2.48M |
|
|
WBA
1075
DELISTED
Walgreens Boots Alliance
WBA
| $11.6M | ﹤0.01% |
1,033,944
-6,841
| -0.7% | -$76.4K |
|